Literature DB >> 7001691

Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria.

A F Aderounmu, L A Salako, S A Adelusi.   

Abstract

Thirty-five children with Plasmodium falciparum malaria were treated with 25 mg/kg chloroquine over three days and observed for seven days during which blood films were examined daily for malaria parasites. Asexual forms of P. falciparum which were present in the blood films of all the patients before commencing treatment disappeared rapidly from the blood so that by the third day no parasites were seen in the blood film. The blood films remained negative for the rest of the seven-day observation period. Plasma chloroquine determination in eight of the patients showed high blood levels during the first three days. The results do not confirm the suspicion of chloroquine-resistant P. falciparum in the area studied although RI level of resistance by WHO criteria was not excluded.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001691     DOI: 10.1016/0035-9203(80)90108-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria.

Authors:  O Walker; A H Dawodu; A A Adeyokunnu; L A Salako; G Alvan
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

Review 2.  Drug resistance in malaria: a review of the west African situation.

Authors:  K O Adubofour
Journal:  J Natl Med Assoc       Date:  1992-12       Impact factor: 1.798

3.  Kinetics of the uptake and elimination of chloroquine in children with malaria.

Authors:  S A Adelusi; A H Dawodu; L A Salako
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

4.  The effect of health education intervention on the home management of malaria among the caregivers of children aged under 5 years in Ogun State, Nigeria.

Authors:  Kehinde O Fatungase; Olorunfemi E Amoran; Kabir O Alausa
Journal:  Eur J Med Res       Date:  2012-05-17       Impact factor: 2.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.